EngageRx for High Blood Pressure

Overseen By Mark Pletcher, MD MPH

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of California, San Francisco

Disqualifiers: Unable to use BP monitor, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 3 months

Trial Summary

What is the purpose of this trial?

This pilot study will support use of EngageRx_SMBP for 70 patients in the UCSF General Internal Medicine practice. The goals of the pilot will be to assess usability and satisfaction of both patients and clinicians, and to describe BP-related process metrics and outcomes including time to intensification of BP medications and/or BP control.

Research Team

Mark Pletcher, MD MPH

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This clinical trial is for patients with high blood pressure being treated at UCSF General Internal Medicine practice. It aims to test the usability and satisfaction of a new self-measurement blood pressure system, EngageRx_SMBP, among 70 participants.

Inclusion Criteria

Lowest SBP > 140 or lowest DBP > 90 during the visit at one of the Mt. Zion General Internal Medicine practices

I am over 18 and have high blood pressure that isn't controlled.

Exclusion Criteria

Patient is unlikely to be able to use a home BP monitor

Cannot understand the verbal consent

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the EngageRx_SMBP system for integrated self-measurement of blood pressure

3 months

Follow-up

Participants are monitored for usability, satisfaction, and BP-related process metrics after treatment

4 weeks

Treatment Details

Interventions

• EngageRx_SMBP

Trial Overview The study is testing EngageRx_SMBP, a tool for patients to measure their own blood pressure. The focus is on how well it works and if people like using it. Researchers will also look at how quickly doctors adjust medications or achieve BP control when using this system.

Participant Groups

Group I: EngageRx_SMBP Experimental Treatment 1 Intervention

Integrated SMBP monitoring using EngageRx_SMBP.

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials

2,636

Recruited

19,080,000+

National Institutes of Health (NIH)

Collaborator

Trials

2,896

Recruited

8,053,000+

New York University

Collaborator

Trials

249

Recruited

229,000+